- Home
- IINN vs ATHA Comparison
IINN vs ATHA Comparison
Compare IINN & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IINN
- ATHA
- Stock Information
- Founded
- IINN 2018
- ATHA 2011
- Country
- IINN Israel
- ATHA United States
- Employees
- IINN N/A
- ATHA N/A
- Industry
- IINN Medical/Dental Instruments
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- IINN Health Care
- ATHA Health Care
- Exchange
- IINN Nasdaq
- ATHA Nasdaq
- Market Cap
- IINN 15.9M
- ATHA 21.0M
- IPO Year
- IINN 2021
- ATHA 2020
- Fundamental
- Price
- IINN $0.61
- ATHA $0.28
- Analyst Decision
- IINN
- ATHA Buy
- Analyst Count
- IINN 0
- ATHA 4
- Target Price
- IINN N/A
- ATHA $11.25
- AVG Volume (30 Days)
- IINN 397.2K
- ATHA 223.9K
- Earning Date
- IINN 05-06-2025
- ATHA 05-14-2025
- Dividend Yield
- IINN N/A
- ATHA N/A
- EPS Growth
- IINN N/A
- ATHA N/A
- EPS
- IINN N/A
- ATHA N/A
- Revenue
- IINN N/A
- ATHA N/A
- Revenue This Year
- IINN N/A
- ATHA N/A
- Revenue Next Year
- IINN N/A
- ATHA N/A
- P/E Ratio
- IINN N/A
- ATHA N/A
- Revenue Growth
- IINN N/A
- ATHA N/A
- 52 Week Low
- IINN $0.54
- ATHA $0.22
- 52 Week High
- IINN $2.45
- ATHA $3.67
- Technical
- Relative Strength Index (RSI)
- IINN 42.48
- ATHA 49.62
- Support Level
- IINN $0.53
- ATHA $0.22
- Resistance Level
- IINN $0.67
- ATHA $0.31
- Average True Range (ATR)
- IINN 0.07
- ATHA 0.03
- MACD
- IINN 0.01
- ATHA 0.01
- Stochastic Oscillator
- IINN 48.76
- ATHA 70.66
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.